Science Corruption News Stories

Excerpts of Key Science Corruption News Stories in Major Media

Top leaders in the field of medicine and science have spoken out about the rampant corruption and conflicts of interest in those industries. Below are key excerpts of revealing news articles on science corruption from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

Note: This comprehensive list of news stories is usually updated once a week. Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

If you follow the news about health research, you risk whiplash. First garlic lowers bad cholesterol, then—after more study—it doesn’t. Hormone replacement reduces the risk of heart disease in postmenopausal women, until a huge study finds that it doesn’t. But what if wrong answers aren’t the exception but the rule? More and more scholars who scrutinize health research are now making that claim. It isn’t just an individual study here and there that’s flawed, they charge. Instead, the very framework of medical investigation may be off-kilter, leading time and again to findings that are at best unproved and at worst dangerously wrong. The result is a system that leads patients and physicians astray—spurring often costly regimens that won’t help and may even harm you. Even a cursory glance at medical journals shows that once heralded studies keep falling by the wayside. A major study concluded there’s no good evidence that statins (drugs like Lipitor and Crestor) help people with no history of heart disease. The study ... was based on an evaluation of 14 individual trials with 34,272 patients. Cost of statins: more than $20 billion per year. “Positive” drug trials, which find that a treatment is effective, and “negative” trials, in which a drug fails, take the same amount of time to conduct. But negative trials took an extra two to four years to be published. With billions of dollars on the line, companies are loath to declare a new drug ineffective. As a result of the lag in publishing negative studies, patients receive a treatment that is actually ineffective. From clinical trials of new drugs to cutting-edge genetics, biomedical research is riddled with incorrect findings.

Note: For the good of your health, the entire article at the link above is well worth reading. For lots more on how the profit-oriented health profession puts public health at risk, click here and here.

Last year, Stanford banned its physicians from giving paid promotional talks for pharmaceutical companies. One thing it didn't do was make sure its faculty followed that rule. A ProPublica investigation ["Dollars for Docs"] found that more than a dozen of the school's doctors were paid speakers in apparent violation of Stanford policy - two of them were paid six figures since last year. Conflict-of-interest policies have become increasingly important as academic medical centers worry that promotional talks undermine the credibility not only of the physicians giving them, but also of the institutions they represent. Yet when it comes to enforcing the policies, universities have allowed permissive interpretations and relied on the honor system. That approach isn't working. Many physicians are in apparent violation, and ignorance or confusion about the rules is widespread. As a result, some faculty physicians stay on the industry lecture circuit, where they can net tens of thousands of dollars in additional income. Critics of the practice say delivering talks for drug companies is incompatible with teaching future generations of physicians. That's because drug firms typically pick the topic of the lecture, train the speakers and require them to use company-provided presentation slides.

Note: "Dollars for Docs" is an ongoing investigation into the influence of drug company marketing payments on medical providers. To search for a doctor in the database, click here.

Reversing a longstanding policy, the federal government said on [October 29] that human and other genes should not be eligible for patents because they are part of nature. The new position could have a huge impact on medicine and on the biotechnology industry. The new position was declared in a friend-of-the-court brief filed by the Department of Justice ... in a case involving two human genes linked to breast and ovarian cancer. “We acknowledge that this conclusion is contrary to the longstanding practice of the Patent and Trademark Office, as well as the practice of the National Institutes of Health and other government agencies that have in the past sought and obtained patents for isolated genomic DNA,” the brief said. The issue of gene patents has long been a controversial [one]. Opponents say that genes are products of nature, not inventions, and should be the common heritage of mankind. They say that locking up basic genetic information in patents actually impedes medical progress. Proponents say genes isolated from the body are chemicals that are different from those found in the body and therefore are eligible for patents. In its brief, the government said it now believed that the mere isolation of a gene, without further alteration or manipulation, does not change its nature.

Note: This is great news. To see how patents have been used in scary ways to promote global monopolies, watch this documentary.

Many drug trials involve a placebo, a sham drug whose results are compared with the results of the real medication. A placebo is supposed to contain a harmless substance, such as sugar or vegetable oil, which has no significant effect on the body. In [a new] study, researchers delved into 176 studies published in reputable medical journals ... from January 2008 to December 2009 to see if placebo contents were disclosed and if so, what they were. The study authors argue that placebo ingredients may not always be as inconsequential as some may think. They write: "For instance, olive oil and corn oil have been used as the placebo in trials of cholesterol-lowering drugs. This may lead to an understatement of drug benefit: The monounsaturated and polyunsaturated fatty acids of these 'placebos,' and their antioxidant and anti-inflammatory effects, can reduce lipid levels and heart disease." Certain placebos, they add, may skew results in favor of the active drug. The researchers referenced a trial for a drug used to treat anorexia linked with cancer in which a lactose placebo was used. Since lactose intolerance is common among cancer patients, the fact that some suffered stomach problems from the placebo may have made the actual drug look more beneficial. "Perfect placebo is not the aim," they write, "rather, we seek to ensure that its composition is disclosed."

Note: For key reports from major media sources on important issues related to health and medicine, click here.

The Nazi doctor Josef Mengele is responsible for the astonishing number of twins in a small Brazilian town, an Argentine historian has claimed. The steely hearted "Angel of Death", whose mission was to create a master race fit for the Third Reich, was the resident medic at Auschwitz from May 1943 until his flight in the face of the Red Army advance in January 1945. His task was to carry out experiments to discover by what method of genetic quirk twins were produced – and then to artificially increase the Aryan birthrate for his master, Adolf Hitler. Now, a historian claims, Mengele's notorious experiments may have borne fruit. For years scientists have failed to discover why as many as one in five pregnancies in a small Brazilian town have resulted in twins – most of them blond haired and blue eyed. But residents of Candido Godoi now claim that Mengele made repeated visits there in the early 1960s, posing at first as a vet but then offering medical treatment to the women of the town. Shuttling between Argentina, Paraguay and Brazil, he managed to evade justice before his death in 1979, but his dreams of a Nazi master race appeared unfulfilled. In a new book, Mengele [in Spanish], the Argentine historian Jorge Camarasa, a specialist in the post-war Nazi flight to South America, has painstakingly pieced together the Nazi doctor's mysterious later years. After speaking to the townspeople of Candido Godoi, he is convinced that Mengele continued his genetic experiments with twins – with startling results.

Note: For more about Josef Mengele, and his relationship with the CIA, click here.

Few ecological disasters have been as confounding as the massive and devastating die-off of the world's honeybees. The phenomenon of Colony Collapse Disorder (CCD) -- in which disoriented honeybees die far from their hives -- has kept scientists, beekeepers, and regulators desperately seeking the cause. The long list of possible suspects has included pests, viruses, fungi, and also pesticides, particularly so-called neonicotinoids, a class of neurotoxins that kills insects by attacking their nervous systems. For years, their leading manufacturer, Bayer Crop Science, a subsidiary of the German pharmaceutical giant Bayer AG (BAYRY), has tangled with regulators and fended off lawsuits from angry beekeepers who allege that the pesticides have disoriented and ultimately killed their bees. A cheer must have gone up at Bayer on Thursday when a front-page New York Times article, under the headline "Scientists and Soldiers Solve a Bee Mystery," described how a newly released study pinpoints a different cause for the die-off: "a fungus tag-teaming with a virus." The Bayer pesticides, however, go unmentioned. What the Times article did not explore -- nor did the study disclose -- was the relationship between the study's lead author, Montana bee researcher Dr. Jerry Bromenshenk, and Bayer Crop Science. In recent years Bromenshenk has received a significant research grant from Bayer to study bee pollination.

Note: Read the full, revealing article to learn how money often corrupts science. For lots more from reliable sources on corporate corruption, click here.

You�re not likely to hear about this from your doctor, but fake medical treatment can work amazingly well. For a range of ailments, from pain and nausea to depression and Parkinson�s disease, placebos--whether sugar pills, saline injections, or sham surgery--have often produced results that rival those of standard therapies. As evidence of the effect�s power mounts, members of the medical community are increasingly asking an intriguing question: if the placebo effect can help patients, shouldn�t we start putting it to work? In certain ways, placebos are ideal drugs: they typically have no side effects and are essentially free. And in recent years, research has confirmed that they can bring about genuine improvements in a number of conditions. An active conversation is now under way in leading medical journals, as bioethicists and researchers explore how to give people the real benefits of pretend treatment. But any attempt to harness the placebo effect immediately runs into thorny ethical and practical dilemmas. To present a dummy pill as real medicine would be, by most standards, to lie. To prescribe one openly, however, would risk undermining the effect. And even if these issues were resolved, the whole idea still might sound a little shady--offering bogus pills or procedures could seem, from the patient�s perspective, hard to distinguish from skimping on care.

Note: For key reports from major media sources on important health issues, click here.

HIV tests detect footprints, never the animal itself. These footprints, antibodies ... were limited to two in 1984 ... but over the years expanded to include many proteins previously not associated with HIV. A majority of HIV-positive tests, when retested, come back indeterminate or negative. In many cases, different results emerge from the same blood tested in different labs. There are currently at least eleven different criteria for how many and what proteins at which band density signal positive. The most stringent criteria (four bands) are upheld in Australia and France; the least stringent (two bands), in Africa, where an HIV test is not even required as part of an AIDS diagnosis. Africa ... has become ground zero of the AIDS epidemic. The clinical definition of AIDS in Africa, however, is stunningly broad and generic, and was seemingly designed to be little other than a signal for funding. The Bangui definition of AIDS ... requires neither a positive HIV test nor a low T-cell count, as in the West, but only the presence of chronic diarrhea, fever, significant weight loss, and asthenia. These happen to be the symptoms of chronic malnutrition, malaria, parasitic infections, and other common African illnesses. The statistical picture of AIDS in Africa, consequently, is a communal projection based on very rough estimates ... extrapolated across the continent using computer models and highly questionable assumptions. More than 2,300 people, mostly scientists and doctors, including Nobelists in chemistry and medicine, have signed the petition of the Group for the Scientific Reappraisal of the HIV-AIDS Hypothesis, which calls for a more independent and skeptical approach to the question of AIDS causality.

Note: If you want to be educated about the details of how rampant corruption has become in the medical research industry, read this well researched article. For a concise description of unbridled corruption in the health care industry by one of the most respected doctors in the world, click here.

Joyce Ann Hafford died without ever holding the son she had tried to save from contracting AIDS by taking an experimental drug regimen administered by government-funded researchers during her pregnancy. But even before her stunned family could grieve, the 33-year-old's death was reverberating among the government's top scientists in Washington. They quickly realized the drugs the HIV-positive woman from Memphis, Tenn., was taking likely caused the liver failure that killed her. Hafford's family members say they were never told NIH had concluded that the experimental drug regimen likely caused her death until the Associated Press gave them copies of NIH's internal case documents this month. They were left to believe Hafford had died from AIDS complications. "They tried to make it sound like she was just sick. They never connected it to the drug," said Rubbie King, Hafford's sister. NIH officials acknowledge that experimental drugs, most likely nevirapine, caused her death. The study during which Hafford died recently led researchers to conclude that nevirapine poses risks when taken over time by certain pregnant women. The family says Hafford seemed unaware of the liver risks. They even kept the bottle of nevirapine showing it had no safety warnings.

Note: If you want to understand just how corrupt and deceitful medical research doctors can be, read the stunning article on this case at this link. This article mentions the little-known fact that "a majority of HIV-positive tests, when retested, come back indeterminate or negative. In many cases, different results emerge from the same blood tested in different labs."

Research universities that accept millions of dollars from oil companies have failed to shield themselves from corporate influence, according to a new study that faults UC Berkeley, UC Davis, Stanford and seven others. Such cozy relationships give energy companies too much control in deciding what research to fund and what faculty should study, says the report from the Center for American Progress, "Big Oil Goes to College". The contracts ... give more control to companies that foot the bill than to researchers, argues the report's author, Jennifer Washburn. "We want to see university research translate into commercial technology, but we don't want the research itself to be directed by individual corporations," she told The Chronicle. "They shouldn't turn California's flagship universities into the research arm of a private corporation." The report found that industry control over research is "poorly defined" in UC Davis' long-term contract with Chevron Technology Ventures. It says industry shares control with faculty at UC Berkeley, and control is fully corporate at Stanford. The report also says none of the three California contracts "requires peer review when selecting faculty research projects."

Note: For lots more from major media sources on corporate corruption, click here.

Government scientists secretly removed body parts from a national serviceman who died after taking part in nerve gas experiments, a new inquest has been told. Up to 200 separate samples were taken from 20-year-old Ronald Maddison's brain, spinal cord, heart and skin - without his family's permission - days after he died at Porton Down, Wiltshire, the government top-secret chemical warfare research base, in 1953. The body parts have since been used in a number of experiments by scientists researching the effects of toxic chemical agents on human tissue. The original inquest, held in secret in 1953, found that Leading Aircraftman Maddison's death was accidental, but the new inquest will examine fresh evidence and decide whether the original verdict still stands. Mr Maddison ... was among hundreds of national servicemen who volunteered in the 1950s and '60s to take part in tests at Porton Down in the belief that they were helping scientists find a cure for the common cold. The airman died less than an hour after 200mg of the highly toxic Sarin nerve agent was placed on layers of cloth on the inside of his arm.

If you want to understand the way prescription drugs are marketed today, have a look at the 1928 book, Propaganda, by Edward Bernays, the father of public relations in America. For Bernays, the public relations business was less about selling things than about creating the conditions for things to sell themselves. When Bernays was working as a salesman for Mozart pianos, for example, he did not simply place advertisements for pianos in newspapers. That would have been too obvious. Instead, Bernays persuaded reporters to write about a new trend: Sophisticated people were putting aside a special room in the home for playing music. Once a person had a music room, Bernays believed, he would naturally think of buying a piano. As Bernays wrote, "It will come to him as his own idea." Just as Bernays sold pianos by selling the music room, pharmaceutical marketers now sell drugs by selling the diseases that they treat. The buzzword is "disease branding." To brand a disease is to shape its public perception in order to make it more palatable to potential patients. Once a branded disease has achieved a degree of cultural legitimacy, there is no need to convince anyone that a drug to treat it is necessary. It will come to him as his own idea. It is hard to brand a disease without the help of physicians, of course. So drug companies typically recruit academic "thought leaders" to write and speak about any new conditions they are trying to introduce.

Note: This key topic is discussed in great depth in the BBC's documentary "Century of the Self" available here. And for a top doctor's analysis that the cholesterol scare was largely manufactured for profit, click here.

The astounding revelation that U.S. medical researchers intentionally gave Guatemalans gonorrhea and syphilis more than 60 years ago is so horrifying that we want to believe that what happened then could never happen today. A report from the United States Department of Health and Human Services noted that roughly 80 percent of drug approvals in 2008 were based in part on data from outside the U.S. Susan Reverby, a distinguished historian at Wellesley College in Massachusetts, has ... long researched the infamous Tuskegee Syphilis Study, the experiment where poor, black men in rural Alabama were deliberately left untreated for syphilis by government researchers. The study, somehow, was allowed to run from 1932 to 1972. More recently, Reverby came across documents that showed that Dr. John C. Cutler, a physician who would later be one of the researchers involved in the Tuskegee study, was involved in a completely unethical research study much earlier in Guatemala. Cutler, who went to his grave defending the Tuskegee experiment, directly inoculated unknowing prisoners in Guatemala with syphilis and also encouraged them to have sex with diseased prostitutes for his research from 1946-48. His work was sponsored by lauded organizations such as the United States Public Health Service, the National Institutes of Health with collaboration of the Pan American Health Sanitary Bureau (now the Pan American Health Organization), and the Guatemalan government.

Note: The author of this commentary is Arthur Caplan, director of the Center for Bioethics at the University of Pennsylvania. For many other examples of government-sponsored experimentation on human guinea pigs, click here.

Nearly two years ago, a study known as the JUPITER [Justification for the Use of Statins in Primary Prevention] trial hinted at a new era in the use of statins -- one in which the cholesterol-busting drugs could be used to stave off heart-related death in many more people than just those with high cholesterol. Now, however, researchers behind a new review that takes a second look at the findings of the landmark study say that these results are flawed -- and that they do not support the benefits initially reported. Not only did this second look turn up no evidence of the "striking decrease in coronary heart disease complications" reported by investigators behind JUPITER, but it has also called into question drug companies' involvement in such trials, according to an article in the June 28 issue of Archives of Internal Medicine. Moreover, Dr. Michel de Lorgeril of Joseph Fourier University and the National Center of Scientific Research in Grenoble, France, and coauthors argue that major discrepancies exists between the significant reductions in nonfatal stroke and heart attacks reported in the JUPITER trial and what has been found in other research. "The JUPITER data set appears biased," Lorgeril and coauthors wrote in conclusion. De Lorgeril and coauthors point out that nine of 14 authors of the JUPITER article have financial relationships with AstraZeneca, which sponsored the trial.

Note: There is intriguing evidence that much of the fear around cholesterol was fabricated to sell drugs. For more on this, see the article by one of the most respected doctors on the Internet at this link.

One of the more controversial topics involving Nikola Tesla is what became of many of his technical and scientific papers after he died in 1943. Just before his death at the height of World War II, he claimed that he had perfected his so-called "death beam." So it was natural that the FBI and other U.S. Government agencies would be interested in any scientific ideas involving weaponry. The morning after the inventor's death, his nephew Sava Kosanovic hurried to his uncle's room at the Hotel New Yorker. By the time he arrived, Tesla's body had already been removed, and Kosanovic suspected that someone had already gone through his uncle's effects. Technical papers were missing as well as a black notebook he knew Tesla kept — a notebook with several hundred pages, some of which were marked "Government." Just after World War II, there was a renewed interest in beam weapons. Copies of Tesla's papers on particle beam weaponry were sent to Patterson Air Force Base in Dayton, Ohio. An operation code-named "Project Nick" was heavily funded and placed under the command of Brigadier General L. C. Craigie to test the feasibility of Tesla's concept. Details of the experiments were never published, and the project was apparently discontinued. But something peculiar happened. The copies of Tesla's papers disappeared and nobody knows what happened to them.

Note: For more on this amazing man, click here and here.

Medical professionals who were involved in the Central Intelligence Agency's interrogations of terrorism suspects engaged in forms of human research and experimentation in violation of medical ethics and domestic and international law, according to a new report from a human rights organization. Doctors, psychologists and other professionals assigned to monitor the C.I.A.'s use of waterboarding, sleep deprivation and other "enhanced" interrogation techniques gathered and collected data on the impact of the interrogations on the detainees in order to refine those techniques. But, by doing so, the medical professionals turned the detainees into research subjects, according to the report ... published on [June 7] by Physicians for Human Rights. "There was no therapeutic purpose or intent to monitor and collect this data," said Jonathan D. Moreno, a professor of medical ethics at the University of Pennsylvania. "You can't use people as laboratories."

Note: To read the full report from Physicians for Human Rights, "Experiments in Torture: Human Subject Research and Evidence of Experimentation in the ‘Enhanced' Interrogation Program", click here.

Disturbing new questions have been raised about the role of doctors and other medical professionals in helping the Central Intelligence Agency subject terrorism suspects to harsh treatment, abuse and torture. The Red Cross previously documented, from interviews with "high-value" prisoners, that medical personnel helped facilitate abuses in the C.I.A.'s "enhanced interrogation program" during the Bush administration. Now Physicians for Human Rights has suggested that the medical professionals may also have violated national and international laws setting limits on what research can be performed on humans. The group's report focused particularly on a few issues where medical personnel played an important role – determining how far a harsh interrogation could go, providing legal cover against prosecution and designing future interrogation procedures. In the case of waterboarding, a technique in which prisoners are brought to the edge of drowning, health professionals were required to monitor the practice and keep detailed medical records. Their findings led to several changes, including a switch to saline solution as the near-drowning agent instead of water, ostensibly to protect the health of detainees who ingest large volumes of liquid but also, the group says, to allow repeated use of waterboarding on the same subject.

Note: For lots more from reliable sources on the unlawful actions of US intelligence and military forces in the "global war on terror," click here.

Hitler and his henchmen victimized an entire continent and exterminated millions in his quest for a so-called Master Race. But the concept of a white, blond-haired, blue-eyed master Nordic race didn't originate with Hitler. The idea was created in the United States, and cultivated in California, decades before Hitler came to power. Eugenics would have been so much bizarre parlor talk had it not been for extensive financing by corporate philanthropies, specifically the Carnegie Institution, the Rockefeller Foundation and the Harriman railroad fortune. They were all in league with some of America's most respected scientists from such prestigious universities as Stanford, Yale, Harvard and Princeton. These academicians espoused race theory and race science, and then faked and twisted data to serve eugenics' racist aims. Stanford President David Starr Jordan originated the notion of "race and blood" in his 1902 racial epistle "Blood of a Nation," in which the university scholar declared that human qualities and conditions such as talent and poverty were passed through the blood. The Rockefeller Foundation helped found the German eugenics program and even funded the program that Josef Mengele worked in before he went to Auschwitz.

Note: Josef Mengele's US-funded eugenics research laid the foundation for his experimentation on human subjects before and during World War II. He went on to participate in CIA-funded mind-control experimentation after that war. For more on Mengele, click here.

Scientists who drew up the key World Health Organisation guidelines advising governments to stockpile drugs in the event of a flu pandemic had previously been paid by drug companies which stood to profit. An investigation by the British Medical Journal and the Bureau of Investigative Journalism, the not-for-profit reporting unit, shows that WHO guidance issued in 2004 was authored by three scientists who had previously received payment for other work from Roche, which makes Tamiflu, and GlaxoSmithKline (GSK), manufacturer of Relenza. Pharmaceutical companies banked more than $7bn (�4.8bn) as governments stockpiled drugs. "The tentacles of drug company influence are in all levels in the decision-making process," said Paul Flynn, the Labour MP who sits on the council's health committee. Although the experts consulted made no secret of industry ties in other settings, declaring them in research papers and at universities, the WHO itself did not publicly disclose any of these in its seminal 2004 guidance.

Note: For wide coverage from reliable sourcesof the swine and avian flu "fake pandemics" designed for corporate profit, click here.

The remains of what has been described as a huge lost city may force historians and archaeologists to radically reconsider their view of ancient human history. Marine scientists say archaeological remains discovered 36 metres (120 feet) underwater in the Gulf of Cambay off the western coast of India could be over 9,000 years old. The vast city - which is five miles long and two miles wide - is believed to predate the oldest known remains in the subcontinent by more than 5,000 years. Debris recovered from the site - including construction material, pottery, sections of walls, beads, sculpture and human bones and teeth has been carbon dated and found to be nearly 9,500 years old. The city is believed to be even older than the ancient Harappan civilisation, which dates back around 4,000 years. Author and film-maker Graham Hancock - who has written extensively on the uncovering of ancient civilisations [said,] "Cities on this scale are not known in the archaeological record until roughly 4,500 years ago when the first big cities begin to appear in Mesopotamia. Nothing else on the scale of the underwater cities of Cambay is known. There's a huge chronological problem in this discovery. It means that the whole model of the origins of civilisation with which archaeologists have been working will have to be remade from scratch," he said.

Note: Dozens of manmade complexes found under the ocean have been found, yet mainstream archeologists are largely ignoring these finds because they don't fit the academic consensus. For an excellent compilation of reliable, mainstream media news articles showing both the hidden history and suppressed archeology of our world, click here. For an interview with former Economist reporter Graham Hancock, who finds lots of solid, astounding evidence of a lost civilization, click here.

Important Note: Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.